Difference between revisions of "Rhabdomyosarcoma"

From Libre Pathology
Jump to navigation Jump to search
(→‎IHC: fix sp.)
Line 126: Line 126:
==Molecular diagnostics==
==Molecular diagnostics==
===Alveolar rhabdomyosarcoma===
===Alveolar rhabdomyosarcoma===
Common translocations (~80%):
Common translocations (~85% of cases):
*t(1,13).
*t(1,13).
**PAX7/FKHR fusion gene.
**PAX7/FKHR fusion gene.
*t(2,13).<ref>URL: [http://www.ncbi.nlm.nih.gov/omim/606597 http://www.ncbi.nlm.nih.gov/omim/606597]. Accessed on: 18 August 2010.</ref>
**Seen in approx. 15% of cases.
*t(2,13) ~ 70% of cases.<ref>URL: [http://www.ncbi.nlm.nih.gov/omim/606597 http://www.ncbi.nlm.nih.gov/omim/606597]. Accessed on: 18 August 2010.</ref>
**PAX3/FKHR fusion gene.
**PAX3/FKHR fusion gene.
**Seen in approx. 70% of cases.


Notes:
Notes:

Revision as of 21:37, 2 May 2011

Rhabdomyosarcoma, often abbreviated RMS, is a malignant tumour of skeletal muscle.

General

  • Most common paediatric sarcoma.
  • ~6% of all childhood cancer.

Classification

Histologic

  1. Alveolar rhabdomyosarcoma.
    • Usually young adults/adolescents.
    • Early mets common.
    • Usu. arises in regions with skeletal muscle.
  2. Embryonal rhabdomyosarcoma.
    • Usual <10 years old.
    • Typically locally invasive.
    • Usu. arises in regions without skeletal muscle.

Molecular and histologic

  1. Translocation-positive alveolar RMS.
  2. Translocation-negative alveolar RMS.
  3. Embryonal RMS.

Notes:

  • Translocation-negative alveolar RMS shares gene expression prolifing characteristics with embryonal RMS -- suggesting these can be grouped together.

Microscopic

Alveolar rhabdomyosarcoma

Features:[1]

  • Alveolus-like pattern -- key low-power feature.
    • Fibrous septae lined by tumour cells.
      • Cells may "fall-off" the septa, i.e. be detached/scattered in the alveolus-like space.
      • Space between fibrous sepate may be filled with tumour = solid variant of alveolar rhabdomyosarcoma.
  • Rhabdomyoblasts - essentially diagnostic.
    • Eccentric nucleus.
    • Moderate amount of intensly eosinophilic cytoplasm.
    • Striations -- if you're really lucky; these are not common.

Other features:

  • Nuclear pleomorphism - common.
  • Mitoses - common.

Notes:

  • Well-differentiated rhabdomyoblasts are uncommon in alveolar RMS.

Embryonal rhabdomyosarcoma

Features:[1]

  • Randomly arranged small cells.
  • Myxoid matrix.
  • Strap cells:
    • Tadpole-like morphology.
  • Rhabdomyoblasts - essentially diagnostic.
    • Eccentric nucleus.
    • Moderate amount of intensly eosinophilic cytoplasm.
    • Striations -- if you're really lucky; these are not common.

Subtypes of embryonal RMS

There are two common subtypes of embryonal RMS. Both of them have a better prognosis that embryonal RMS not otherwise specified (NOS).

Common subtypes:

  1. Botryoid subtype:
    • Gross: Grape-like morphology.
    • Microscopic: Non-proliferating layer deep to the surface ("Cambrian layer").
  2. Spindle cell subtype.
    • General: may mimic leiomyosarcoma -- which is not common in the pediatric population.
    • Microscopic: vesicular growth pattern, spindle cells.

Anaplasia

Criteria:

  1. Hyperchromatic nuclei with size variation greater or equal to 3x.
  2. Multipolar (atypical) mitotic figures.

Subclassification:

  1. Focal - a few cells.
  2. Diffuse - cluster or sheets of anaplasia.

Notes:

  • Not subtle - can identify at low power.
  • Seen in 10-15% of RMS.
    • More common in older individuals.
  • Poorer prognosis in embryonal RMS.
    • No change in prognosis in alveolar RMS.

IHC

Panel of muscle markers -- DAM:

  • Desmin (best marker).
  • Actin.
  • Myogenin.

Subtyping via IHC

PST proposes[1] the following (presumably based on Makawitz et al.[2]):

IHC Translocation positive
alveolar RMS 		Embryonal RMS Translocation negative
alveolar RMS
myogenin +ve -- diffuse +ve -- focal +ve -- diffuse
EGFR -ve +ve -ve
P-cadherin +ve -ve -ve
IGF2 -ve +ve +ve

A paper by Wachtel at al.[3] proposes the use of:

  • AP2beta and P-cadherin +ve in translocation positive alveolar RMS, and
  • EGFR and fibrillin-2 +ve in embryonal RMS and translocation negative alveolar RMS.

Electron microscopy

Features:

  • Sarcomeric like structures - usu. in "bent" cells; cells that are U-shaped.

Molecular diagnostics

Alveolar rhabdomyosarcoma

Common translocations (~85% of cases):

  • t(1,13).
    • PAX7/FKHR fusion gene.
    • Seen in approx. 15% of cases.
  • t(2,13) ~ 70% of cases.[4]
    • PAX3/FKHR fusion gene.
    • Seen in approx. 70% of cases.

Notes:

  • t(1,13) vs. t(2,13) -- t(1,13) usually: younger age, extremity lesion, localized disease, better survival.
  • Several uncommon translocations exist.

See also

References

  1. ↑ 1.0 1.1 1.2 PST. 14 February 2011.
  2. ↑ Makawita S, Ho M, Durbin AD, Thorner PS, Malkin D, Somers GR (2009). "Expression of insulin-like growth factor pathway proteins in rhabdomyosarcoma: IGF-2 expression is associated with translocation-negative tumors". Pediatr. Dev. Pathol. 12 (2): 127–35. doi:10.2350/08-05-0477.1. PMID 18788888.
  3. ↑ Wachtel M, Runge T, Leuschner I, et al. (February 2006). "Subtype and prognostic classification of rhabdomyosarcoma by immunohistochemistry". J. Clin. Oncol. 24 (5): 816–22. doi:10.1200/JCO.2005.03.4934. PMID 16391296.
  4. ↑ URL: http://www.ncbi.nlm.nih.gov/omim/606597. Accessed on: 18 August 2010.
Retrieved from "https://librepathology.org/w/index.php?title=Rhabdomyosarcoma&oldid=5113"